Toronto Dominion Bank Abb Vie Inc. Transaction History

Toronto Dominion Bank

$61.6 Billion
Q2 2024

A detailed history of Toronto Dominion Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Toronto Dominion Bank holds 941,351 shares of ABBV stock, worth $186 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

941,351

Previous 1,078,336 12.7%

Holding current value

$186 Million

Previous $196 Million 17.78%

% of portfolio

0.26%

Previous 0.31%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $21.2 Million - $24.8 Million	-136,985 Reduced 12.7%	941,351 $161 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $3.58 Million - $4.08 Million	22,404 Added 2.12%	1,078,336 $196 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $2.4 Million - $2.7 Million	17,413 Added 1.68%	1,055,932 $164 Million
Q3 2023 Feb 14, 2024	SELL	$133.59 - $154.65 $4.45 Million - $5.15 Million	-33,293 Reduced 3.11%	1,038,519 $155 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $4.45 Million - $5.15 Million	-33,293 Reduced 3.11%	1,038,519 $155 Million
Q2 2023 Feb 14, 2024	BUY	$132.51 - $164.9 $2.1 Million - $2.62 Million	15,880 Added 1.5%	1,071,812 $144 Million
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $223,014 - $277,526	-1,683 Reduced 0.16%	1,071,812 $144 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $10.2 Million - $11.7 Million	70,240 Added 7.0%	1,073,495 $171 Million
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $23.3 Million - $27.9 Million	168,330 Added 20.16%	1,003,255 $162 Million
Q3 2022 Nov 09, 2022	SELL	$134.21 - $153.93 $19 Million - $21.8 Million	-141,332 Reduced 14.48%	834,925 $112 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $19.5 Million - $24.8 Million	-141,651 Reduced 12.67%	976,257 $149 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $1.17 Million - $1.45 Million	8,846 Added 0.8%	1,117,908 $181 Million
Q4 2021 Feb 04, 2022	SELL	$107.43 - $135.93 $16.9 Million - $21.4 Million	-157,172 Reduced 12.41%	1,109,062 $150 Million
Q3 2021 Nov 08, 2021	BUY	$106.4 - $120.78 $42.3 Million - $48 Million	397,222 Added 45.71%	1,266,234 $137 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $91.4 Million - $102 Million	869,012 New	869,012 $97.9 Million

Others Institutions Holding ABBV

# of Institutions

3,695

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $349B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.

Account

Toronto Dominion Bank Abb Vie Inc. Transaction History